SK286160B6 - Použitie dexmedetomidínu na výrobu liečiva - Google Patents

Použitie dexmedetomidínu na výrobu liečiva Download PDF

Info

Publication number
SK286160B6
SK286160B6 SK1436-2000A SK14362000A SK286160B6 SK 286160 B6 SK286160 B6 SK 286160B6 SK 14362000 A SK14362000 A SK 14362000A SK 286160 B6 SK286160 B6 SK 286160B6
Authority
SK
Slovakia
Prior art keywords
dexmedetomidine
patient
sedation
patients
icu
Prior art date
Application number
SK1436-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK14362000A3 (sk
Inventor
Riku Aantaa
Romeo Bachand
Esa Heinonen
Original Assignee
Orion Corporation
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26763325&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SK286160(B6) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Corporation, Abbott Laboratories filed Critical Orion Corporation
Publication of SK14362000A3 publication Critical patent/SK14362000A3/sk
Publication of SK286160B6 publication Critical patent/SK286160B6/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • A61K31/4174Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SK1436-2000A 1998-04-01 1999-03-31 Použitie dexmedetomidínu na výrobu liečiva SK286160B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8028798P 1998-04-01 1998-04-01
US11094498P 1998-12-04 1998-12-04
PCT/FI1999/000266 WO1999049854A2 (en) 1998-04-01 1999-03-31 Use of dexmedetomidine for icu sedation

Publications (2)

Publication Number Publication Date
SK14362000A3 SK14362000A3 (sk) 2002-03-05
SK286160B6 true SK286160B6 (sk) 2008-04-07

Family

ID=26763325

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1436-2000A SK286160B6 (sk) 1998-04-01 1999-03-31 Použitie dexmedetomidínu na výrobu liečiva

Country Status (27)

Country Link
EP (1) EP1069893B1 (pl)
JP (1) JP4606581B2 (pl)
KR (1) KR20010034728A (pl)
CN (1) CN1168441C (pl)
AR (1) AR015744A1 (pl)
AT (1) ATE347359T1 (pl)
AU (1) AU754484B2 (pl)
BG (1) BG64540B1 (pl)
BR (1) BR9909872A (pl)
CA (1) CA2326339C (pl)
CZ (1) CZ301013B6 (pl)
DE (1) DE69934305T2 (pl)
DK (1) DK1069893T3 (pl)
EA (1) EA005524B1 (pl)
ES (1) ES2278441T3 (pl)
GB (1) GB2352972B (pl)
HU (1) HU229162B1 (pl)
IL (1) IL138416A (pl)
NO (1) NO329194B1 (pl)
NZ (1) NZ507203A (pl)
PL (1) PL192517B1 (pl)
PT (1) PT1069893E (pl)
SI (1) SI1069893T1 (pl)
SK (1) SK286160B6 (pl)
TR (1) TR200002837T2 (pl)
TW (1) TW552136B (pl)
WO (1) WO1999049854A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU778522B2 (en) 1999-10-29 2004-12-09 Orion Corporation Treatment or prevention of hypotension and shock
HUP0600241A2 (en) * 2002-04-08 2006-07-28 Mgi Gp Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
US7141597B2 (en) * 2003-09-12 2006-11-28 Allergan, Inc. Nonsedating α-2 agonists
US20060058700A1 (en) * 2004-08-26 2006-03-16 Marro Dominic P Patient sedation monitor
US20080119820A1 (en) 2006-09-20 2008-05-22 Phan Phillip C Methods for Delivering Volatile Anesthetics for Regional Anesthesia and/or Pain Relief
EP2244737B1 (en) 2008-01-22 2019-04-10 The Board of Regents of The University of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
CA2762107A1 (en) * 2009-05-15 2010-11-18 Recro Pharma, Inc. Sublingual dexmedetomidine compositions and methods of use thereof
DE102009050016A1 (de) 2009-05-27 2011-05-05 Modine Manufacturing Co., Racine Wärmeübertragereinheit
US20130096170A1 (en) * 2011-10-14 2013-04-18 Hospira, Inc. Methods of treating pediatric patients using dexmedetomidine
EP2787970B1 (en) 2011-12-11 2018-04-11 Recro Pharma, Inc. Intranasal dexmedetomidine compositions and methods of use thereof
US8242158B1 (en) * 2012-01-04 2012-08-14 Hospira, Inc. Dexmedetomidine premix formulation
JP5921928B2 (ja) * 2012-03-28 2016-05-24 テルモ株式会社 既希釈デクスメデトミジン製剤
ES2659271T3 (es) * 2012-10-15 2018-03-14 Orion Corporation Método veterinario para aliviar la aversión al ruido
WO2015011177A1 (en) 2013-07-24 2015-01-29 I-Tech Ab Use of the enantiomer levomedetomidine as inhibitor for marine biofouling of surfaces
EP3054930B1 (en) * 2013-10-07 2020-12-02 Teikoku Pharma USA, Inc. Methods and compositions for transdermal delivery of a non-sedative amount of dexmedetomidine
CN105764494A (zh) 2013-10-07 2016-07-13 帝国制药美国公司 右旋美托咪啶经皮递送装置及其使用方法
WO2015054059A2 (en) * 2013-10-07 2015-04-16 Teikoku Pharma Usa, Inc. Methods and compositions for treating attention deficit hyperactivity disorder, anxiety and insomnia using dexmedetomidine transdermal compositions
CN113975273B (zh) * 2020-07-27 2023-07-11 宜昌人福药业有限责任公司 一种抗焦虑用纳米混悬鼻腔喷雾剂及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
FI844786A0 (fi) * 1984-12-04 1984-12-04 Farmos Oy Terapeutiskt utnyttjbar foerening.
GB2206880B (en) * 1987-07-16 1991-04-24 Farmos Oy Optical isomers of an imidazole derivative
GB2215206B (en) * 1988-02-29 1991-07-03 Farmos Oy 4-substituted imidazole derivatives useful in perioperative care
US5344840A (en) * 1988-02-29 1994-09-06 Orion-Yhtyma Oy 4-substituted imidazole derivatives useful in perioperative care
US5124157A (en) * 1989-08-18 1992-06-23 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
US5217718A (en) * 1989-08-18 1993-06-08 Cygnus Therapeutic Systems Method and device for administering dexmedetomidine transdermally
FI894911A0 (fi) * 1989-10-17 1989-10-17 Farmos Oy En terapeutiskt vaerdefull foerening.
GB2281206A (en) * 1993-08-25 1995-03-01 Orion Yhtymae Oy Use of dexmedetomidine

Also Published As

Publication number Publication date
WO1999049854A3 (en) 1999-11-18
GB0024932D0 (en) 2000-11-29
EA200001010A1 (ru) 2001-02-26
NZ507203A (en) 2003-03-28
DE69934305D1 (de) 2007-01-18
BR9909872A (pt) 2007-11-20
JP4606581B2 (ja) 2011-01-05
BG64540B1 (bg) 2005-07-29
CA2326339C (en) 2008-12-23
NO329194B1 (no) 2010-09-13
IL138416A0 (en) 2001-10-31
NO20004931L (no) 2000-09-29
JP2002509880A (ja) 2002-04-02
AR015744A1 (es) 2001-05-16
PT1069893E (pt) 2007-01-31
ATE347359T1 (de) 2006-12-15
AU3149499A (en) 1999-10-18
DE69934305T2 (de) 2007-07-12
GB2352972B (en) 2003-05-21
IL138416A (en) 2005-07-25
CN1295473A (zh) 2001-05-16
TR200002837T2 (tr) 2001-01-22
EA005524B1 (ru) 2005-04-28
ES2278441T3 (es) 2007-08-01
BG104797A (en) 2001-07-31
PL343553A1 (en) 2001-08-27
HUP0101498A1 (hu) 2002-03-28
TW552136B (en) 2003-09-11
CZ301013B6 (cs) 2009-10-14
NO20004931D0 (no) 2000-09-29
GB2352972A (en) 2001-02-14
SK14362000A3 (sk) 2002-03-05
HUP0101498A3 (en) 2002-06-28
EP1069893A2 (en) 2001-01-24
WO1999049854A2 (en) 1999-10-07
CA2326339A1 (en) 1999-10-07
AU754484B2 (en) 2002-11-14
SI1069893T1 (sl) 2007-04-30
EP1069893B1 (en) 2006-12-06
PL192517B1 (pl) 2006-10-31
DK1069893T3 (da) 2007-03-19
CZ20003484A3 (cs) 2002-01-16
HU229162B1 (hu) 2013-09-30
KR20010034728A (ko) 2001-04-25
CN1168441C (zh) 2004-09-29

Similar Documents

Publication Publication Date Title
SK286160B6 (sk) Použitie dexmedetomidínu na výrobu liečiva
US6716867B1 (en) Use of dexmedetomidine for ICU sedation
Raval et al. Oral clonidine pre medication for attenuation of haemodynamic response to laryngoscopy and intubation
Smiley et al. Dexmedetomidine sedation with and without midazolam for third molar surgery
Guglielminotti et al. Effects of premedication on dose requirements for propofol: comparison of clonidine and hydroxyzine.
Adachi et al. Small dose midazolam or droperidol reduces the hypnotic dose of propofol at the induction of anaesthesia
Abel Rahman et al. Efficacy of different dexmedetomidine regimens in producing controlled hypotensive anesthesia during functional endoscopic sinus surgery
Dyson Analgesia and chemical restraint for the emergent veterinary patient
Mikati et al. Anesthetic implications in alternating hemiplegia of childhood: A case report
Pekcan How can better anaesthetic combinations be performed? A review of current knowledge
Kecik et al. A case of acute poisoning due to organophosphate insecticide
Ramya A Comparative Study Of Dexmedetomidine Versus Midazolam For Monitored Anaesthesia Care In Middle Ear Surgeries
Pathmanathan 10 Sedation and delirium
Tryba Alpha2-adrenoceptor agonists in intensive care medicine: Prevention and treatment of withdrawal
Mamatha Comparative Study Between Dexmedetomidine and Midazolam in Inducing Conscious Sedation in Patient Undergoing Cataract Surgery
FRH Comparison of Intrathecal Dexmedetomidine and Buprenorphine as Adjuvant to Bupivacaine for Lower Limb Surgeries
Han et al. Effects of prophylactic nalbuphine on emergence agitation and postoperative pain in pediatric patients undergoing ENT surgery with sevoflurane anesthesia
Sehrawat et al. Clonidine Infusion as Premedication in Hypertensive Patients: A Randomised Controlled Study
Awasthi et al. A comparison among different doses of dexmedetomidine in attenuating extubation response in patients undergoing open cholecystectomy
Duda The good, bad, and ugly: Using ketamine for ED pediatric patients
Álvarez-Juárez Adjuvant Drugs to Decrease the Adrenergic Response in Conventional Laryngoscopy
WO2008043211A1 (fr) Utilisation de la kétansérine pour la préparation de médicaments prévenant l'apoplexie cérébrale
Gupta Comparison of Dexmedetomidine, Propofol and Midazolam for Sedation in Intensive Care Unit
Reddy et al. Effect of oral Clonidine premedication before anaesthesia: Double blindprospective randomized study.
Evans Dexmedetomidine and Pediatric Emergence Agitation.

Legal Events

Date Code Title Description
PC4A Assignment and transfer of rights

Owner name: ORION CORPORATION, ESPOO, FI

Free format text: FORMER OWNER: ORION CORPORATION, ESPOO, FI; ABBOTT LABORATORIES, ABBOTT PARK, IL, US

Effective date: 20161111

MK4A Expiry of patent

Expiry date: 20190331